Phase 1 Investor (defunct)

If you’ve subscribed to Phase 1 Investor (defunct), please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.

Investment Performance

No votes yet... cast yours!
No votes yet.
Please wait...
Your vote

Quality Of Writing/Analysis

No votes yet... cast yours!
No votes yet.
Please wait...
Your vote

Value For Price

No votes yet... cast yours!
No votes yet.
Please wait...
Your vote

Customer Service

No votes yet... cast yours!
No votes yet.
Please wait...
Your vote
guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

16 Comments
Inline Feedbacks
View all comments
Rob L.
Rob L.
March 30, 2009 6:39 pm

Stansberry & Associates: Phase One Investor

Remember this teaser?

“On March 30, FDA results we’ve waited 2 years to receive could make you $195,600, overnight!”

Well, March 30 has arrived! The results are in! And indeed you COULD have made $195,600…if you had SHORTED Arena Pharmaceuticals instead of BUYING it, the way Phase One pounded the table to have you do! Rather than soar over $10 a share, which could “change your life” and “allow you to literally quit work, forever!”…the stock plunged from $4.50 to a low of $2.85 today, before settling in with “only” a loss of 28%, at $3.23.

I’m guessing people will take the next pronouncements from Phase One Investor with an entire shaker of salt. Of course, since the Stansberry folks write such good copy, they might make it interesting enough to stoke some people’s curiosity. Not mine, though.

Add a Topic
3022
Add a Topic
5971
Michael Murphy, CFA
Guest
April 8, 2009 2:18 pm

Hey, Rob L., Phase 1 never recommended buying ARNA! They said DON’T buy the stock, buy a call spread. They sold the spread after the announcement for a 40% loss and then recommended selling the July $2.50 put for enough money to get the loss back.

But, overall, Phase 1 does not seem to “get” stock valuation, and tends to gloss over the negatives, so a lot of their recommendations hit their 25% stop loss and disappear.

Plus, it is really expensive.

Disclosure: My newsletter, New World Investor, competes in part with Phase 1. Also, after the sharp drop I recently recommended buying ARNA.

Add a Topic
5971
Add a Topic
5971